Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?

Thromboembolic events contribute to morbidity and mortality in coronavirus disease 2019 (COVID-19). As a result, thromboprophylaxis using low-molecular-weight heparin (LMWH) is universally recommended for hospitalized patients based on multiple guidelines. However, ethnic differences with respect to...

Descripción completa

Detalles Bibliográficos
Autores principales: Iba, Toshiaki, Connors, Jean Marie, Spyropoulos, Alex C., Wada, Hideo, Levy, Jerrold H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816059/
https://www.ncbi.nlm.nih.gov/pubmed/33471294
http://dx.doi.org/10.1007/s12185-021-03078-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816059/
https://www.ncbi.nlm.nih.gov/pubmed/33471294
http://dx.doi.org/10.1007/s12185-021-03078-x

Ejemplares similares